Stimuli-Responsive Programmed Specific Targeting in Nanomedicine.
Level V
Where this comes from
- Record sourced from PubMed, PMID 26881288.
- Also identified by DOI 10.1021/acsnano.6b00870 and PMC identifier 5223089.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Both passive targeting and actively enhanced cellular internalization play significant roles in tumor-targeted therapy. Programmed specific targeting, as a novel targeting strategy that exploits stimuli-responsive structures, expects that nanocarriers show high stability during blood circulation for efficient passive targeting, then respond to tumor internal or external stimuli and transform into more cell-interactive forms upon arrival at the tumor tissue for enhanced cellular internalization. In this Perspective, we introduce recent advances in the design and development of stimuli-responsive programmed specific targeting nanomedicines, which are based on switchable surface charge, activatable targeting molecules, and variable coatings, to combine the advantages of passive targeting and actively enhanced cellular internalization.
Medical subject headings
- Delayed-Action Preparations
- Drug Delivery Systems
- Nanoparticles